Skip to main content
Fig. 3 | BMC Neurology

Fig. 3

From: Monoclonal antibodies against CGRP (R): non-responders and switchers: real world data from an austrian case series

Fig. 3

Responder rates for patients with EM or CM who switched mAb-class and received a second CGRP-antibody due to lack or loss of effectiveness of the first monoclonal antibody (N = 26). Absolute numbers are given; percentages can be gathered from the y-axis. Patients who were first treated with a CGRP-receptor received a CGRP-ligand as second drug and vice versa

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us